• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球范围内幽门螺杆菌感染的流行情况:一项具有国家代表性的研究的系统综述。

Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage.

机构信息

Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School, Al. Prof. Hernâni Monteiro, 4200-319, Porto, Portugal,

出版信息

Dig Dis Sci. 2014 Aug;59(8):1698-709. doi: 10.1007/s10620-014-3063-0. Epub 2014 Feb 22.

DOI:10.1007/s10620-014-3063-0
PMID:24563236
Abstract

The systematic assessment of large population-based surveys addressing the prevalence of Helicobacter pylori infection may provide robust evidence for understanding the trends in the exposure to this major risk factor across settings with distinct patterns of gastric cancer variation. Our aim was to describe the prevalence of H. pylori infection in different countries and periods, through systematic review of the literature. We searched PubMed from inception up to September 2013 to identify original studies reporting on the prevalence of H. pylori, and only those evaluating samples with national coverage were included. We identified 37 eligible studies including data for 22 countries. The prevalences were higher in Central/South America and Asia, and at least two-fold higher in countries with high gastric cancer incidence. In most countries presenting data for different time periods, the prevalences were usually lower in the most recent surveys. However, there was little variation in settings where prevalences were already low. Among countries with high prevalence of H. pylori infection there is an ample scope for reducing its burden in the next decades, whereas further declines in settings with already low prevalences will require more intensive efforts.

摘要

系统评估大规模基于人群的调查,以确定幽门螺杆菌感染的流行率,可能为了解在胃癌变化模式不同的环境中接触这一主要危险因素的趋势提供有力的证据。我们的目的是通过文献系统回顾,描述不同国家和时期的幽门螺杆菌感染流行率。我们检索了 PubMed 从创建到 2013 年 9 月的数据,以确定报告幽门螺杆菌流行率的原始研究,并且只包括评估具有全国代表性样本的研究。我们共发现 37 项符合条件的研究,其中包括 22 个国家的数据。在中/南美洲和亚洲,幽门螺杆菌感染的流行率较高,而在胃癌发病率较高的国家,其流行率至少高出两倍。在大多数提供不同时期数据的国家中,最近的调查中流行率通常较低。但是,在流行率已经较低的地区,变化很小。在幽门螺杆菌感染流行率高的国家中,在未来几十年中,减少其负担的空间很大,而在流行率已经较低的地区进一步下降,则需要更密集的努力。

相似文献

1
Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage.全球范围内幽门螺杆菌感染的流行情况:一项具有国家代表性的研究的系统综述。
Dig Dis Sci. 2014 Aug;59(8):1698-709. doi: 10.1007/s10620-014-3063-0. Epub 2014 Feb 22.
2
Contemporary migration patterns in the prevalence of Helicobacter pylori infection: A systematic review.幽门螺杆菌感染流行率的当代迁移模式:一项系统综述。
Helicobacter. 2017 Jun;22(3). doi: 10.1111/hel.12372. Epub 2017 Jan 18.
3
Non-invasive diagnostic tests for Helicobacter pylori infection.幽门螺杆菌感染的非侵入性诊断测试。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
4
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.用于根除幽门螺杆菌的序贯疗法与标准三联一线疗法对比
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
7
Helicobacter pylori eradication for the prevention of gastric neoplasia.根除幽门螺杆菌以预防胃部肿瘤
Cochrane Database Syst Rev. 2015 Jul 22;2015(7):CD005583. doi: 10.1002/14651858.CD005583.pub2.
8
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.亚太地区幽门螺杆菌的主要抗生素耐药性:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7.
9
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析。
Cochrane Database Syst Rev. 2015 Dec 22;2015(12):CD011841. doi: 10.1002/14651858.CD011841.pub2.
10
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.幽门螺杆菌根除与胃癌发病率的关系:系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.

引用本文的文献

1
Prevalence and risk factors of infection in urban children aged 6-13 years in Fuzhou, China: a cross-sectional study in a high gastric cancer incidence region.中国福州6-13岁城市儿童感染的患病率及危险因素:一项在胃癌高发地区的横断面研究
Front Pediatr. 2025 Jul 16;13:1457195. doi: 10.3389/fped.2025.1457195. eCollection 2025.
2
Contribution of Interleukin-4 Promoter Genotypes to Gastric Cancer Risk in Taiwan.白细胞介素-4启动子基因型对台湾地区胃癌风险的影响
In Vivo. 2025 Jul-Aug;39(4):1912-1923. doi: 10.21873/invivo.13990.
3
The Aging Stomach: Clinical Implications of Infection in Older Adults-Challenges and Strategies for Improved Management.

本文引用的文献

1
Model-based patterns in stomach cancer mortality worldwide.全球胃癌死亡率的基于模型的模式。
Eur J Cancer Prev. 2014 Nov;23(6):524-31. doi: 10.1097/CEJ.0b013e328364f2b6.
2
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.筛查和治疗幽门螺杆菌预防胃癌的成本效益。
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):933-47. doi: 10.1016/j.bpg.2013.09.005. Epub 2013 Sep 27.
3
Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years.
衰老的胃:老年人感染的临床意义——改善管理的挑战与策略
Int J Mol Sci. 2024 Nov 28;25(23):12826. doi: 10.3390/ijms252312826.
4
Genetic Determinants of Clarithromycin and Fluoroquinolones Resistance in in Serbia.塞尔维亚克拉霉素和氟喹诺酮类耐药性的遗传决定因素
Antibiotics (Basel). 2024 Oct 1;13(10):933. doi: 10.3390/antibiotics13100933.
5
Efficacy of Magnifying Endoscopy with Narrow-Band Imaging in the Diagnosis of Early Gastric Cancer and Gastric Intraepithelial Neoplasia.窄带成像放大内镜在早期胃癌及胃上皮内瘤变诊断中的效能
Turk J Gastroenterol. 2024 Feb 16;35(4):299-306. doi: 10.5152/tjg.2024.23116.
6
Pepsinogen I, pepsinogen II, gastrin-17, and serological biomarkers in the diagnosis of precursor lesions of gastric cancer.胃蛋白酶原I、胃蛋白酶原II、胃泌素-17及血清学生物标志物在胃癌前病变诊断中的应用
Arch Med Sci. 2024 Jun 28;20(3):1016-1021. doi: 10.5114/aoms/189971. eCollection 2024.
7
antibiotic resistance profile in Chinese children with upper gastrointestinal symptoms and a literature review for developing personalized eradicating strategies.中国有上消化道症状儿童的抗生素耐药性概况及制定个性化根除策略的文献综述
Front Pharmacol. 2024 Jun 3;15:1392787. doi: 10.3389/fphar.2024.1392787. eCollection 2024.
8
Assessment of cytotoxin-associated Gene A (Cag A) protein and its association with ferritin and vitamin B12 deficiencies among adult healthy asymptomatic residents in Sharjah, United Arab Emirates.阿拉伯联合酋长国沙迦成年健康无症状居民中细胞毒素相关基因A(Cag A)蛋白的评估及其与铁蛋白和维生素B12缺乏的关联。
Heliyon. 2024 May 29;10(11):e32141. doi: 10.1016/j.heliyon.2024.e32141. eCollection 2024 Jun 15.
9
JAK3/STAT5 signaling-triggered upregulation of PIK3CD contributes to gastric carcinoma development.JAK3/STAT5信号传导引发的PIK3CD上调促进胃癌发展。
J Cell Commun Signal. 2024 Feb 7;18(1):e12017. doi: 10.1002/ccs3.12017. eCollection 2024 Mar.
10
The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh.益生菌在根除幽门螺杆菌中的作用及对消化性溃疡治疗的总体影响:一项针对孟加拉国接受三联疗法患者的研究
Cureus. 2024 Mar 16;16(3):e56283. doi: 10.7759/cureus.56283. eCollection 2024 Mar.
韩国幽门螺杆菌感染的流行状况和危险因素:一项全国多中心研究超过 13 年。
BMC Gastroenterol. 2013 Jun 24;13:104. doi: 10.1186/1471-230X-13-104.
4
Childcare attendance and Helicobacter pylori infection: systematic review and meta-analysis.儿童保育出勤率与幽门螺杆菌感染:系统评价和荟萃分析。
Eur J Cancer Prev. 2013 Jul;22(4):311-9. doi: 10.1097/CEJ.0b013e32835b69aa.
5
Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.拉脱维亚幽门螺杆菌感染和萎缩性胃炎的流行情况。
Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1410-7. doi: 10.1097/MEG.0b013e3283583ca5.
6
Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults.黎巴嫩成年人中幽门螺杆菌感染与胰岛素抵抗和代谢综合征的关系。
Helicobacter. 2012 Dec;17(6):444-51. doi: 10.1111/j.1523-5378.2012.00970.x. Epub 2012 Jul 3.
7
Significant decrease in prevalence of Helicobacter pylori in the Czech Republic.在捷克共和国,幽门螺杆菌的流行率显著下降。
World J Gastroenterol. 2012 Aug 28;18(32):4412-8. doi: 10.3748/wjg.v18.i32.4412.
8
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.2008 年归因于感染的癌症全球负担:综述和综合分析。
Lancet Oncol. 2012 Jun;13(6):607-15. doi: 10.1016/S1470-2045(12)70137-7. Epub 2012 May 9.
9
Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood.幽门螺杆菌与出生队列效应:儿童时期定植率稳定的证据。
Helicobacter. 2011 Oct;16(5):405-9. doi: 10.1111/j.1523-5378.2011.00854.x.
10
The role of Helicobacter pylori infection in the web of gastric cancer causation.幽门螺杆菌感染在胃癌发病机制中的作用。
Eur J Cancer Prev. 2012 Mar;21(2):118-25. doi: 10.1097/CEJ.0b013e32834a7f66.